Crohn's Disease Clinical Trials

A listing of Crohn's Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Research Site
Additional Locations Alabama

A Multicenter Study to Measure the Transfer of Cimzia® From Women to Infants Via the Placenta (CRIB)

View More ▼

UPDATED

Mobile Alabama

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Birmingham Alabama 35209

A clinical trial to evaluate treatments using ABT-494 and Placebo for patients with Crohn's Disease

Dothan Alabama

A clinical trial to evaluate treatments using GS-5745 and Placebo for patients with Crohn's Disease

Dothan Alabama 36305

Patients are needed to participate in a clinical research study of Adalimumab to evaluate Crohn's Disease

Huntsville Alabama 35802

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Alaska

Research Site
Additional Locations Alaska

A Multicenter Study to Measure the Transfer of Cimzia® From Women to Infants Via the Placenta (CRIB)

Arizona

Research Site
Additional Locations Arizona

A Multicenter Study to Measure the Transfer of Cimzia® From Women to Infants Via the Placenta (CRIB)

View More ▼

UPDATED

Phoenix Arizona

A Phase 2 clinical study for patients with Active, Moderate to Severe Crohn's Disease

UPDATED

Phoenix Arizona

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

UPDATED

Tucson Arizona 85710

A clinical trial to evaluate treatments using RHB-104 and Placebo for patients with Crohn's Disease

Scottsdale Arizona 85260

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Scottsdale Arizona

A clinical trial to evaluate treatments using GS-5745 and Placebo for patients with Crohn's Disease

Tucson Arizona 85724

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85712

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85741

A clinical research study of RPC1063 for the treatment of Crohn's Disease, Moderate to Severe

Tucson Arizona 85712

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85741

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Arkansas

Research Site
Additional Locations Arkansas

A Multicenter Study to Measure the Transfer of Cimzia® From Women to Infants Via the Placenta (CRIB)

View More ▼

Little Rock Arkansas 72205

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Little Rock Arkansas 72211

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

North Little Rock Arkansas 72117

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

North Little Rock Arkansas 72117

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease, Mild to Moderate

Sherwood Arkansas 72120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

California

Research Site
Additional Locations California

A Multicenter Study to Measure the Transfer of Cimzia® From Women to Infants Via the Placenta (CRIB)

Precision Research Institute
San Diego California 92114

A phase II, multicenter, randomized, double-blind, multiple dose, placebo-controlled, parallel-group study to evaluate the efficacy, pharmacokinetics, and safety of BI 655066, an IL-23 p19 antagonist monoclonal antibody, in patients with moderately to severely active Crohn’s Disease, who are naïve to, or were previously treated with anti- TNF therapy.

View More ▼

UPDATED

Anaheim California 92801

A clinical trial to evaluate treatments using RHB-104 and Placebo for patients with Crohn's Disease

UPDATED

La Jolla California

Patients are needed to participate in a clinical research study of Vedolizumab to evaluate Crohn's Disease

UPDATED

La Mirada California 90638

A clinical trial to evaluate treatments using RHB-104 and Placebo for patients with Crohn's Disease

UPDATED

Los Angeles California

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

UPDATED

Oakland California

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

UPDATED

San Carlos California 94070

A clinical trial to evaluate treatments using RHB-104 and Placebo for patients with Crohn's Disease

UPDATED

San Diego California

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

UPDATED

San Francisco California

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

UPDATED

Ventura California 93003

A clinical trial to evaluate treatments using RHB-104 and Placebo for patients with Crohn's Disease

Bakersfield California 93301

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Garden Grove California 92845

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

La Jolla California 92093

A clinical trial to evaluate treatments using ABT-494 and Placebo for patients with Crohn's Disease

La Jolla California

A clinical trial to evaluate treatments using GS-5745 and Placebo for patients with Crohn's Disease

La Jolla California 92037

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

La Mirada California 90638

A clinical trial to evaluate treatments using ABT-494 and Placebo for patients with Crohn's Disease

La Mirada California 90638

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Laguna Hills California 92653

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Los Angeles California 90067

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Los Angeles California

A clinical trial to evaluate treatments using GS-5745 and Placebo for patients with Crohn's Disease

Los Angeles California 90045

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Los Angeles California 91403

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles California 90036

Patients are needed to participate in a clinical research study of Adalimumab to evaluate Crohn's Disease